Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.49 USD | +23.88% | +2.47% | -79.98% |
05-14 | Earnings Flash (VVOS) VIVOS THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
04-01 | Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-79.98% | 5.99M | |
+73.70% | 12.4B | |
-17.02% | 7.94B | |
-1.68% | 6.17B | |
+16.74% | 5.55B | |
-3.21% | 5.35B | |
+46.20% | 5.03B | |
-17.47% | 4.07B | |
-29.91% | 2.65B | |
-0.74% | 1.99B |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Roth Capital Lowers Price Target for Vivos Therapeutics to $8 From $9.75, Maintains Buy Rating